Delivery Order SPE2DR25D2009-SPE2DR26FJ4L9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count) with a ceiling value of $1,525.55. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by December 17, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,498.56 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count) on November 5, 2025, with completion scheduled for November 6, 2025. This non-competitive, firm fixed-price delivery order was fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, representing a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,548.09 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,059.94 to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 25 mg capsules (100 count) on December 18, 2025, with completion targeted for December 19, 2025. This competitively awarded, firm fixed-price delivery order was placed under a non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the...
- The Defense Logistics Agency awarded a $3,103.86 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for dextroamphetamine-amphetamine 25 mg capsules (100 count). This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by December 4, 2025. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,024.06 to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 20 mg capsules (100 count) on December 16, 2025, with completion due by December 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal pharmaceutical supply agreements. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,632.24 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of July 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a single delivery order issued under the...
- The Defense Logistics Agency awarded a delivery order valued at $1,414.29 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100-count units). This firm fixed-price, competitively awarded contract with no set-aside designation was executed on December 19, 2025, with an ultimate completion date of December 22, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,014.76 for Dextroamphetamine-Amphetamine 30 mg capsules (100-count) on October 29, 2025, with completion scheduled for October 30, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a single delivery order transaction under AmerisourceBergen's broader federal pharmaceutical supply agreements. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $1,707.46 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count). This firm fixed-price contract, which carries an ultimate completion date of December 11, 2025, represents a non-set-aside competitive award to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ4L9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,110.24 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on December 19, 2025, with an ultimate completion date of December 22, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a task order issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement that runs through December 2026 and serves as the primary pharmaceutical supply vehicle for global military healthcare programs. As the prime contractor on this IDC, AmerisourceBergen supplies a comprehensive range of pharmaceutical products, medical devices, and healthcare commodities to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive federal contract portfolio demonstrates its established capability to fulfill critical pharmaceutical procurement requirements through competitive federal acquisition channels.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 12/18/25 |